Corbus is committed to leveraging our expertise in immunology to fulfill our purpose of developing innovative new medicines t ... hat improve the lives of people living with inflammatory, fibrotic, and metabolic diseases, and cancer. Corbus’ current pipeline includes small molecules that activate or inhibit the endocannabinoid system and anti-integrin monoclonal antibodies that block activation of TGFβ. read more